S-Ruxolitinib: a novel JAK/STAT-targeted therapy through restoring mucosal homeostasis for chronic rhinosinusitis with nasal polyps

Journal:
The Journal of Allergy and Clinical Immunology
Published:
DOI:
10.1016/j.jaci.2025.07.020
Affiliations:
9
Authors:
11
Go to article
Institutions Authors Share
Beijing Tongren Hospital, Capital Medical University, China
5.666667
 0.52
Beijing Key Laboratory of Nasal Diseases, China
4.333333
 0.39
University Hospital of Münster (UKM), WWU, Germany
1.000000
 0.09
Interested in Clinical Sciences?